methylophiopogonanone B: from Ophiopogon japonicus plant extract, inhibits melanosome transfer in human epidermal melanocytes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Ophiopogon | genus | A plant genus of the family Asparagaceae. Members contain steroidal glycosides and provide an ingredient of shengmaisan (DRUGS, CHINESE HERBAL).[MeSH] | Asparagaceae | A family of flowering subshrubs and shrubs in the class Magnoliopsida.[MeSH] |
| Ophiopogon japonicus | species | [no description available] | Asparagaceae | A family of flowering subshrubs and shrubs in the class Magnoliopsida.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 46886723 |
| CHEMBL ID | 1098293 |
| MeSH ID | M0510396 |
| Synonym |
|---|
| CHEMBL1098293 |
| 74805-91-7 |
| methylophiopogonanone b |
| 4h-1-benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6,8-dimethyl-, (3r)- |
| AC-34356 |
| methylophiopogonanone b, analytical standard |
| 8-methylophiopogonanone b |
| mfcd20487835 |
| AKOS032948998 |
| CS-0022656 |
| HY-N2438 |
| A865798 |
| MS-24920 |
| (3r)-5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6,8-dimethyl-2,3-dihydrochromen-4-one |
| (3r)-2,3-dihydro-5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6,8-dimethyl-4h-1-benzopyran-4-one |
| DTXSID101313976 |
| methylophiopogonanoneb |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID477213 | Increase in insulin-stimulated [3H]2-deoxy-D-glucose uptake in mouse 3T3L1cells at 1 uM after 3 days by liquid scintillation counting relative to insulin | 2010 | Journal of natural products, Apr-23, Volume: 73, Issue:4 | Homoisoflavonoids from the fibrous roots of Polygonatum odoratum with glucose uptake-stimulatory activity in 3T3-L1 adipocytes. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.64) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||